1. Home
  2. SUPN vs CMPR Comparison

SUPN vs CMPR Comparison

Compare SUPN & CMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

N/A

Current Price

$41.74

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Logo Cimpress plc (Ireland)

CMPR

Cimpress plc (Ireland)

HOLD

Current Price

$84.40

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
CMPR
Founded
2005
1994
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.2B
IPO Year
2010
2005

Fundamental Metrics

Financial Performance
Metric
SUPN
CMPR
Price
$41.74
$84.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$61.60
$86.50
AVG Volume (30 Days)
511.5K
167.8K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
553.45
EPS
N/A
3.79
Revenue
$392,755,000.00
$3,736,643,000.00
Revenue This Year
$22.70
$10.43
Revenue Next Year
$19.14
$5.46
P/E Ratio
N/A
$22.51
Revenue Growth
N/A
9.80
52 Week Low
$41.50
$56.34
52 Week High
$59.68
$106.58

Technical Indicators

Market Signals
Indicator
SUPN
CMPR
Relative Strength Index (RSI) 29.75 33.98
Support Level N/A $80.73
Resistance Level $52.33 $105.61
Average True Range (ATR) 1.28 3.03
MACD -0.38 -0.26
Stochastic Oscillator 2.24 4.91

Price Performance

Historical Comparison
SUPN
CMPR

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

About CMPR Cimpress plc (Ireland)

Cimpress PLC helps millions of businesses build brands, stand out, and grow via customized physical marketing products and branded merchandise. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. It has five segments VistaPrint, PrintBrothers, The Print Group, National Pen, and All Other Businesses. Majority of revenue comes from VistaPrint segment which provides graphic design services, VistaCreate for do-it-yourself (DIY) design, etc. It has presence in North America, Europe, and Other. The company generates majority of revenue is from Europe.

Share on Social Networks: